Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | RO7300490 |
Trade Name | |
Synonyms | RO-7300490|RO 7300490|FAP-CD40 |
Drug Descriptions |
RO7300490 is a bispecific antibody that targets CD40 and FAP, which may activate CD40 at tumor stromal and lead to antitumor activity (PMID: 34043482, PMID: 33771854). |
DrugClasses | CD40 Antibody 14 |
CAS Registry Number | NA |
NCIT ID | C180677 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + RO7300490 | Atezolizumab RO7300490 | 0 | 1 |
RO7300490 | RO7300490 | 0 | 1 |